Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: Here Come The IPOs Again As Bellus Raises $70m And Vir Joins The Queue

Sep 05 2019

• By Mandy Jackson

Finance Watch

Related Content

Novo Outbid As Sanofi Agrees €3.9bn Ablynx Acquisition

Jan 29 2018

Finance Watch: Turning Point Launches IPO, Stock Rises 60% On First Day

Apr 17 2019

Finance Watch: Among Multiple Mega-Rounds, Revolution Raises $100m For RAS Programs

Jul 12 2019

SpringWorks Launches With $103m, Four Pfizer Drugs And A Focus On Underserved Patients

Sep 25 2017

IPO Update: 28 Biopharma Companies Raise $3bn, Provide An Average 10% Return

Jun 28 2019

VC Roundup: Infectious Disease Startup Snags $150m And Former Biogen CEO Scangos

Jan 08 2017

In Hep B, Functional Cure Likely Means Two-Part Combination Process

Nov 23 2017

Pipeline Watch: Phase II/III Start With Nipocalimab, Phase III With Verdiperstat

Aug 05 2019

$500m And Counting: Vir Puts Big Money To Work In Infectious Diseases

Oct 19 2017

IPO Update: TiGenix Debuts In December After Motif Launched In November As 2016 Offerings Best 2015

Dec 14 2016

Aerie Looks To Grow Its Two Glaucoma Products In Tandem

Mar 13 2019

Finance Watch: A One-Time Treatment For Heart Disease? Verve Raises $58.5m To Give It A Try

May 07 2019

Finance Watch: Five IPOs Launch In Two Days; Three Remain In Positive Territory

May 10 2019

Related Companies

BELLUS Health Inc.

Vir Biotechnology, Inc.

Biogen, Inc.

Alnylam Pharmaceuticals Inc.

SpringWorks Therapeutics Inc.

Pfizer Inc.

IGM Biosciences, Inc.

Satsuma Pharmaceuticals, Inc.

Turning Point Therapeutics Inc.

Aerie Pharmaceuticals, Inc.

Zealand Pharma A/S

Galapagos NV

Ablynx N.V.

Sanofi

Novan, Inc.

Spring Bank Pharmaceuticals Inc.

Larimar Therapeutics, Inc.

Additional Topics

Financing Business Strategies Strategy Deals Commercial BioPharmaceutical

More from Financing

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.